Your browser doesn't support javascript.
loading
Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial.
Hamaguchi, Masahide; Hashimoto, Yoshitaka; Tanaka, Toru; Hasegawa, Goji; Ishii, Michiyo; Okada, Hiroshi; Mitsuhashi, Kazuteru; Kitagawa, Noriyuki; Ushigome, Emi; Yamazaki, Masahiro; Fukui, Michiaki.
Afiliación
  • Hamaguchi M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Hashimoto Y; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Tanaka T; Department of Diabetes and Endocrinology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Hasegawa G; Division of Metabolism, Nephrology and Rheumatology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Ishii M; Department of Internal Medicine, Otsu City Hospital, Otsu, Japan.
  • Okada H; Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Mitsuhashi K; Department of Diabetes and Internal Medicine, Fukuchiyama City Hospital, Fukuchiyama, Japan.
  • Kitagawa N; Department of Diabetology, Kameoka Municipal Hospital, Kameoka, Japan.
  • Ushigome E; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Yamazaki M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Fukui M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Clin Med Insights Endocrinol Diabetes ; 14: 11795514211040539, 2021.
Article en En | MEDLINE | ID: mdl-34602832

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Med Insights Endocrinol Diabetes Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Med Insights Endocrinol Diabetes Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos